SKYBIOTECH HEALTHCARE last traded at ₹118.15 (2026-10-13). Over the past month the stock moved -2.2%, three months the stock moved -14.9%, year the stock moved -41.1%. Its closing range over 52 weeks is ₹113.90 – ₹209.65, with the latest close 43.6% below the high.
Closing prices up to 2026-10-13.
Incorporated in 1983, Skybiotech Healthcare Ltd is in the business of Textile and Pharmaceuticals[1]
Business Overview:[1] SBHCL was engaged in the Textile business and was not generating any revenue from its main business activity. It acquired 72.52% stake in M/s. Skybiotech Lifescience Private Limited which become their subsidiary and is engaged in manufacturing Pharmaceutical Products and ingredients
In the latest quarter (Jun 2026), SKYBIOTECH HEALTHCARE reported sales of ₹0.49 crore (-79.5%) and net profit of ₹-0.57 crore, compared with the same quarter last year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Jun 2026 | 0.49 | -0.53 | -108.16 | -0.57 | -2.98 |
| Mar 2026 | 1.83 | -0.88 | -48.09 | -0.30 | -1.57 |
| Dec 2025 | 0.96 | -0.45 | -46.88 | -0.48 | -2.51 |
| Sep 2025 | 1.92 | -0.23 | -11.98 | -0.31 | -1.62 |
| Jun 2025 | 2.39 | 0.08 | 3.35 | -0.02 | -0.10 |
| Mar 2025 | 1.02 | -1.09 | -106.86 | -1.08 | -5.64 |
| Dec 2024 | 2.52 | -0.31 | -12.30 | -0.39 | -2.04 |
| Sep 2024 | 1.60 | 0.02 | 1.25 | -0.25 | -1.31 |
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Sales growth | – | – | +20.0% | -61.9% | +79.4% | -79.5% |
| Operating profit growth | – | – | -1250.0% | – | – | -762.5% |
| Net profit growth | -200.9% | -108.0% | – | – | – | – |
| EPS growth | -200.9% | -107.6% | – | – | – | – |
| OPM % | -106.9% | 3.4% | -12.0% | -46.9% | -48.1% | -108.2% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
In the latest year (Mar 2026), SKYBIOTECH HEALTHCARE reported sales of ₹7.10 crore (+0.7%) and net profit of ₹-1.12 crore, compared with the previous year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Mar 2026 | 7.10 | -1.48 | -20.85 | -1.12 | -5.85 |
| Mar 2025 | 7.05 | -2.25 | -31.91 | -2.37 | -12.38 |
| Mar 2024 | 0.00 | -0.12 | – | 1.54 | 8.04 |
| Mar 2025 | Mar 2026 | |
|---|---|---|
| Sales growth | – | +0.7% |
| Operating profit growth | – | – |
| Net profit growth | -253.9% | – |
| EPS growth | -254.0% | – |
| OPM % | -31.9% | -20.9% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
No AI analysis generated yet for SKYBIOTECH HEALTHCARE.
Get Free AI Stock Analysis FREE →No recent news available for SKYBIOTECH HEALTHCARE.
SKYBIOTECH HEALTHCARE shares were last quoted at ₹118.15 (+1.0% on the day). Use the Refresh price button on this page for the latest available price. Prices are for information only.
SKYBIOTECH HEALTHCARE has a price-to-earnings (P/E) ratio of -522.95 and a price-to-book (P/B) ratio of 2.97. The industry P/E is 46.70.
The 52-week high of SKYBIOTECH HEALTHCARE is ₹220.00 and the 52-week low is ₹115.00.
The market capitalisation of SKYBIOTECH HEALTHCARE is about ₹22.03 crore.
In the latest quarter (Jun 2026), SKYBIOTECH HEALTHCARE reported sales of ₹0.49 crore (-79.5%) and net profit of ₹-0.57 crore, compared with the same quarter last year.
Promoters hold about 63.48% of SKYBIOTECH HEALTHCARE.
SKYBIOTECH HEALTHCARE belongs to the Textiles sector.